The new class of GLP-1 weight loss drugs have been blockbusters since they arrived on the market a few years ago. These ...

The potential health benefits of GLP-1 diabetes and weight loss meds keep piling up: New research shows they may also shield ...

Popular weight loss drugs have been linked to gastrointestinal, mental health, and vision problems, but the benefits appear ...

About 42% of U.S. adults are obese, the CDC says. GLP-1 medications have changed the picture for people hoping to reduce ...

As use of GLP-1 weight loss drugs including Wegovy and Ozempic increases, brands are introducing new offerings.

In its announcement, the Biden administration called anti-obesity medicines “life-saving drugs,” noting that they can also ...

As the popularity of drugs like Ozempic and Mounjaro soar, researchers, doctors, biotechs, and diagnostic firms see a role ...

GLP-1 agonists, such as Ozempic, are “almost starting to look like wonder drugs,” one expert said. But do the benefits extend ...

In 2024, coverage for obesity drugs increased to 44% among employers with 500 or more workers, compared to 41% last year, the ...

The FDA’s decision to allow the compounding of GLP-1 weight loss drugs could undermine its public health obligations, writes ...

New research from The George Institute of Global Health shows that a popular class of obesity and type 2 diabetes drugs can ...